Large-scale testing (Phase 3)Active Not RecruitingNCT06550076What this trial is testingTAK-279 in Participants With Moderate-to-Severe Plaque PsoriasisWho this might be right forPlaque Psoriasis Takeda 2,099
Post-approval studies (Phase 4)Study completedNCT04306315What this trial is testingAdjusted Brodalumab Dose Compared With Standard Brodalumab Dose in Subjects With Moderate-to-severe Plaque Psoriasis and ≥120 kg Body WeightWho this might be right forPsoriasis Vulgaris LEO Pharma 385
Not applicableStudy completedNCT04398732What this trial is testingStudy to Evaluate the Efficacy of Enbrel as a Biological Treatment in Moderate to Severe Plaque Psoriasis PatientsWho this might be right forPlaque Psoriasis Pfizer 486
Post-approval studies (Phase 4)UnknownNCT00707070What this trial is testingCombining Acitretin and Efalizumab in the Therapy of Chronic Plaque PsoriasisWho this might be right forChronic Plaque Psoriasis Universita di Verona 100
Testing effectiveness (Phase 2)Study completedNCT01045577What this trial is testingA Double-blind, Placebo-controlled, Randomized, Parallel-group Study to Evaluate the Activity of Oral AB1010 in Adults Patients With Moderate to Severe Chronic Plaque PsoriasisWho this might be right forPsoriasis AB Science 25
Not applicableStudy completedNCT00800982What this trial is testingOpen Label Study Etanercept's Maintenance Dose in Obese Patients With Moderate to Severe Plaque Type PsoriasisWho this might be right forPsoriasis University of California, San Francisco 30
Testing effectiveness (Phase 2)Study completedNCT02785185What this trial is testingSafety and Efficacy of IDP-122 Lotion When Applied Topically to Subjects With Moderate to Severe Plaque PsoriasisWho this might be right forPsoriasis Bausch Health Americas, Inc. 150
Testing effectiveness (Phase 2)Ended earlyNCT03329885What this trial is testingExperimental Medication BMS-986251, Taken by Mouth, in Healthy Participants and Patients With Average to Very Serious PsoriasisWho this might be right forRheumatoid ArthritisPsoriasisAnkylosing Spondylitis+2 more Bristol-Myers Squibb 38
Testing effectiveness (Phase 2)Active Not RecruitingNCT07290569What this trial is testingDose Ranging Study of ORKA-001 in Patients With Moderate-to-Severe Plaque PsoriasisWho this might be right forPlaque Psoriasis Oruka Therapeutics, Inc. 160
Large-scale testing (Phase 3)Study completedNCT05637515What this trial is testingHulio Interchangeability to Humira®, Comparing Pharmacokinetics, Efficacy, Safety and ImmunogenicityWho this might be right forModerate Chronic Plaque PsoriasisSevere Chronic Plaque Psoriasis Biocon Biologics Inc. 374
Testing effectiveness (Phase 2)Temporarily pausedNCT04121143What this trial is testingA Clinical Study of SHR-1314 Injection in the Treatment of Moderate to Severe Plaque Psoriasis in AdultsWho this might be right forPlaque Psoriasis Jiangsu HengRui Medicine Co., Ltd. 120
Not applicableLooking for participantsNCT06701513What this trial is testingA Real-world Study to Evaluate the Effectiveness of Deucravacitinib in Adults With Plaque Psoriasis in France (RePhlect)Who this might be right forPsoriasis Bristol-Myers Squibb 350
Large-scale testing (Phase 3)Study completedNCT00106834What this trial is testingThe Safety and Efficacy of Infliximab in Patients With PsoriasisWho this might be right forPsoriasis Centocor, Inc. 378
Early research (Phase 1)Study completedNCT02993471What this trial is testingIxekizumab in Participants With Plaque PsoriasisWho this might be right forPsoriasis Eli Lilly and Company 28
Post-approval studies (Phase 4)Not Yet RecruitingNCT07485764What this trial is testingMetformin Combined With Secukinumab for Moderate-to-Severe Plaque Psoriasis in Overweight or Obese Chinese PatientsWho this might be right forPsoriasisPlaque PsoriasisModerate-to-severe Plaque Psoriasis+1 more Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 186
Large-scale testing (Phase 3)Study completedNCT02561806What this trial is testingIxekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsoriasisWho this might be right forPlaque Psoriasis Eli Lilly and Company 302
Large-scale testing (Phase 3)Ended earlyNCT00833053What this trial is testingDose Optimization of Infliximab in Moderate to Severe Plaque Psoriasis (Study P05315)Who this might be right forPsoriasis Merck Sharp & Dohme LLC 39
Large-scale testing (Phase 3)Study completedNCT04785326What this trial is testingEfficacy, Safety, and Immunogenicity of Subcutaneous DMB-3115 Versus Stelara® in Patients With Moderate to Severe Chronic Plaque PsoriasisWho this might be right forModerate to Severe Chronic Plaque Psoriasis Dong-A ST Co., Ltd. 598
Not applicableStudy completedNCT02305953What this trial is testingCytokines and Vascular Inflammation in PsoriasisWho this might be right forVascular InflammationPsoriasisCoronary Atherosclerosis Innovaderm Research Inc. 96
Post-approval studies (Phase 4)Study completedNCT03739853What this trial is testingSevere Psoriatic Arthritis - Early intervEntion to Control Disease: the SPEED TrialWho this might be right forPsoriatic Arthritis University of Oxford 192